{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:38:55Z","timestamp":1790912335595,"version":"4.1.0"},"reference-count":25,"publisher":"Japan Atherosclerosis Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2023,11,1]]},"DOI":"10.5551\/jat.64091","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T22:10:19Z","timestamp":1678313419000},"page":"1612-1621","source":"Crossref","is-referenced-by-count":4,"title":["Malondialdehyde-Modified Low-Density Lipoprotein as a Predictor of Major Adverse Limb Events after Endovascular Therapy in Patients with Lower Extremity Arterial Disease"],"prefix":"10.5551","volume":"30","author":[{"given":"Masashi","family":"Yokoi","sequence":"first","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Kawada","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Mizoguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Nakasuka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Kitada","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Criqui MH, Matsushita K, Aboyans V, Hess CN, Hicks CW, Kwan TW, McDermott MM, Misra S, Ujueta F; American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Lifestyle and Cardiometabolic Health; Council on Peripheral Vascular Disease; and Stroke Council. Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association. Circulation, 2021; 144: e171-e191","DOI":"10.1161\/CIR.0000000000001005"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Stavroulakis K, Torsello G, Bosiers M, Argyriou A, Tsilimparis N, Bisdas T. 2-Year Outcomes of the Eluvia Drug-Eluting Stent for the Treatment of Complex Femoropopliteal Lesions. JACC Cardiovasc Interv, 2021; 14: 692-701","DOI":"10.1016\/j.jcin.2021.01.026"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3) Suzuki K, Ueshima D, Higashitani M, Yamauchi Y, Hozawa K, Hayakawa N, Tobita K, Ogata K, Ohmine T, Nakamura M. Two-year results of endovascular therapy for femoropopliteal artery disease in Japan during the introduction of drug-eluting devices. Cardiovasc Interv Ther, 2022; 10.1007\/s12928-022-00873-z","DOI":"10.1007\/s12928-022-00873-z"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kim J, Park TK, Choi KH, Choi D, Ko YG, Lee JH, Yoon CH, Chae IH, Yu CW, Min PK, Lee SW, Lee SR, Koh YS, Choi SH; Korean Vascular Intervention Society (K-VIS) Endovascular therapy in Lower Limb Artery diseases (ELLA) Registry Investigators. Different association between renal dysfunction and clinical outcomes according to the presence of diabetes in patients undergoing endovascular treatment for peripheral artery disease. J Vasc Surg, 2020; 71: 132-140.e1","DOI":"10.1016\/j.jvs.2019.03.071"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Stone PA, Schlarb H, Campbell JE, Williams D, Thompson SN, John M, Campbell JR, AbuRahma AF. C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization. J Vasc Surg, 2014; 60: 652-660","DOI":"10.1016\/j.jvs.2014.03.254"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Iida O, Nakamura M, Yamauchi Y, Fukunaga M, Yokoi Y, Yokoi H, Soga Y, Zen K, Suematsu N, Inoue N, Suzuki K, Hirano K, Shintani Y, Miyashita Y, Urasawa K, Kitano I, Tsuchiya T, Kawamoto K, Yamaoka T, Uesugi M, Shinke T, Oba Y, Ohura N, Uematsu M, Takahara M, Hamasaki T, Nanto S; OLIVE Investigators. 3-Year Outcomes of the OLIVE Registry, a Prospective Multicenter Study of Patients With Critical Limb Ischemia: A Prospective, Multi-Center, Three-Year Follow-Up Study on Endovascular Treatment for Infra-Inguinal Vessel in Patients With Critical Limb Ischemia. JACC Cardiovasc Interv, 2015; 8: 1493-1502","DOI":"10.1016\/j.jcin.2015.07.005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Bor\u00e9n J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, Daemen MJ, Demer LL, Hegele RA, Nicholls SJ, Nordestgaard BG, Watts GF, Bruckert E, Fazio S, Ference BA, Graham I, Horton JD, Landmesser U, Laufs U, Masana L, Pasterkamp G, Raal FJ, Ray KK, Schunkert H, Taskinen MR, van de Sluis B, Wiklund O, Tokgozoglu L, Catapano AL, Ginsberg HN. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J, 2020; 41: 2313-2330","DOI":"10.1093\/eurheartj\/ehz962"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Amaki T, Suzuki T, Nakamura F, Hayashi D, Imai Y, Morita H, Fukino K, Nojiri T, Kitano S, Hibi N, Yamazaki T, Nagai R. Circulating malondialdehyde modified LDL is a biochemical risk marker for coronary artery disease. Heart, 2004; 90: 1211-1213","DOI":"10.1136\/hrt.2003.018226"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Yokoi M, Ito T, Fujita H, Sugiura T, Seo Y, Ohte N. Increased Serum Malondialdehyde-Modified Low-Density Lipoprotein and Coronary Angiographic Progression After Drug-Eluting Stent Implantation in Patients With Stable Angina. Circ J, 2020; 84: 1837-1845","DOI":"10.1253\/circj.CJ-20-0060"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Ito T, Fujita H, Tani T, Ohte N. Malondialdehyde-modified low-density lipoprotein is a predictor of cardiac events in patients with stable angina on lipid-lowering therapy after percutaneous coronary intervention using drug-eluting stent. Atherosclerosis, 2015; 239: 311-317","DOI":"10.1016\/j.atherosclerosis.2015.01.026"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kotani K, Maekawa M, Kanno T, Kondo A, Toda N, Manabe M. Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum. Biochim Biophys Acta, 1994; 1215: 121-125","DOI":"10.1016\/0005-2760(94)90100-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Sugiuchi H, Irie T, Uji Y, Ueno T, Chaen T, Uekama K, Okabe H. Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and alpha-cyclodextrin sulfate. Clin Chem, 1998; 44: 522-531","DOI":"10.1093\/clinchem\/44.3.522"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K; Japan Atherosclerosis Society Committee for Epidemiology and Clinical Management of Atherosclerosis. Diagnosis of atherosclerosis. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan\u20142012 Version. J Atheroscler Thromb, 2014; 21: 296-298","DOI":"10.5551\/jat.15792"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, Umemoto S, Egusa G, Ohmura H, Okamura T, Kihara S, Koba S, Saito I, Shoji T, Daida H, Tsukamoto K, Deguchi J, Dohi S, Dobashi K, Hamaguchi H, Hara M, Hiro T, Biro S, Fujioka Y, Maruyama C, Miyamoto Y, Murakami Y, Yokode M, Yoshida H, Rakugi H, Wakatsuki A, Yamashita S; Committee for Epidemiology and Clinical Management of Atherosclerosis. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017. J Atheroscler Thromb, 2018; 25: 846-984","DOI":"10.5551\/jat.GL2017"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg, 1997; 26: 517-538","DOI":"10.1016\/S0741-5214(97)70045-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) TASC Steering Committee; Jaff MR, White CJ, Hiatt WR, Fowkes GR, Dormandy J, Razavi M, Reekers J, Norgren L. An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Vasc Med, 2015; 20: 465-478","DOI":"10.1177\/1358863X15597877"},{"key":"17","unstructured":"17) Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR, Murad MH; GVG Writing Group. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg, 2019; 69: 3S-125S.e40"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Hess CN, Rogers RK, Wang TY, Fu R, Gundrum J, Allen LaPointe NM, Hiatt WR. Major Adverse Limb Events and 1-Year Outcomes After Peripheral Artery Revascularization. J Am Coll Cardiol, 2018; 72: 999-1011","DOI":"10.1016\/j.jacc.2018.06.041"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Anand SS, Caron F, Eikelboom JW, Bosch J, Dyal L, Aboyans V, Abola MT, Branch KRH, Keltai K, Bhatt DL, Verhamme P, Fox KAA, Cook-Bruns N, Lanius V, Connolly SJ, Yusuf S. Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS Trial. J Am Coll Cardiol, 2018; 71: 2306-2315","DOI":"10.1016\/j.jacc.2018.03.008"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Takamura TA, Tsuchiya T, Oda M, Watanabe M, Saito R, Sato-Ishida R, Akao H, Kawai Y, Kitayama M, Kajinami K. Circulating malondialdehyde-modified low-density lipoprotein (MDA-LDL) as a novel predictor of clinical outcome after endovascular therapy in patients with peripheral artery disease (PAD). Atherosclerosis, 2017; 263: 192-197","DOI":"10.1016\/j.atherosclerosis.2017.06.029"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Wolf D, Ley K. Immunity and Inflammation in Atherosclerosis. Circ Res, 2019; 124: 315-327","DOI":"10.1161\/CIRCRESAHA.118.313591"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Salonen JT, Yl\u00e4-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyss\u00f6nen K, Palinski W, Witztum JL. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet, 1992; 339: 883-887","DOI":"10.1016\/0140-6736(92)90926-T"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Kenney WL, Cannon JG, Alexander LM. Cutaneous microvascular dysfunction correlates with serum LDL and sLOX-1 receptor concentrations. Microvasc Res, 2013; 85: 112-117","DOI":"10.1016\/j.mvr.2012.10.010"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Gliozzi M, Scicchitano M, Bosco F, Musolino V, Carresi C, Scarano F, Maiuolo J, Nucera S, Maretta A, Paone S, Mollace R, Ruga S, Zito MC, Macr\u00ec R, Oppedisano F, Palma E, Salvemini D, Muscoli C, Mollace V. Modulation of Nitric Oxide Synthases by Oxidized LDLs: Role in Vascular Inflammation and Atherosclerosis Development. Int J Mol Sci, 2019; 20: 3294","DOI":"10.3390\/ijms20133294"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med, 2011; 364: 656-665","DOI":"10.1056\/NEJMra0910283"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/11\/30_64091\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T04:32:28Z","timestamp":1699072348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/11\/30_64091\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.64091","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,1]]},"article-number":"64091"}}